Overview
Xi Lin practices practicing medicine in Guangzhou, China.
Their clinical expertise encompasses Lymphofollicular Hyperplasia, Breast Cancer, Triple-Negative Breast Cancer, and Adenoid Cystic Carcinoma.
They are actively involved in clinical research, co-authoring 26 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Xi Lin
Is Xi Lin a top-rated expert for Lymphofollicular Hyperplasia?
MediFind is an objective health platform that identifies experts based on real-world data. Xi Lin is classified as an Experienced expert for Lymphofollicular Hyperplasia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Xi Lin participate in research or clinical trials?
Yes. Xi Lin has published 26 articles and abstracts on conditions like Lymphofollicular Hyperplasia. You can view a list of Xi Lin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Adenoid Cystic CarcinomaLin isExperienced. Learn about Adenoid Cystic Carcinoma.
- Breast CancerLin isExperienced. Learn about Breast Cancer.
- Lymphofollicular Hyperplasia
- Triple-Negative Breast Cancer